Ideally the transcatheter aortic prosthesis should restrain the native leaflets and relieve stenosis, without unnecessary impingement upon the aorta, left ventricle or outflow tract. [24] Issues ...
October 10, 2012 (London, United Kingdom) — New data--including results from registries in Latin America, Asia, and parts of Europe--suggest that rates of pacemaker implantation following ...
The approval is based on the positive results depicted by the High Risk study of the CoreValve U.S. Pivotal Trial, where the CoreValve System has shown superior clinical outcomes compared to ...
A new aortic heart valve does not require open heart surgery. The CoreValve®Evolut™ R System is deployed with a catheter, which is inserted into an artery and guided to the heart. The artificial valve ...
Next-Generation TAVI System Offers Ability to Recapture and Reposition During Deployment MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM ...
For patients with a degenerated surgically implanted aortic bioprosthesis who are not candidates for reoperation, transarterial implantation of a CoreValve replacement may be a safe and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results